A new study has unraveled a crucial link between how cancer cells cope with replication stress and the role of Taurine Upregulated Gene 1 (TUG1). By targeting TUG1 with a drug, the researchers were able to control brain tumor growth in mice, suggesting a potential strategy to combat aggressive brain tumors such as glioblastomas.
Opinion | FDA Drug Approvals: Let Us See All the Evidence
Kaplan is a researcher and an expert in clinical research standards. Approval of a novel drug by the FDA garners worldwide respect. It signals that
August 28, 2023